The Praetorian Labs team was tasked with identifying novel and previously undocumented persistence mechanisms for use in red team engagements. Our primary focus was on persistence techniques ...

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

There were about 50 funding events in the insurtech sector in January, according to a review by Digital Insurance.

Artificial intelligence (AI) has increasingly moved to the core of strategic decision making across industries globally and remains a hot topic for the coming year.

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Things are moving quickly in AI — and if you’re not keeping up, you’re falling behind. Two recent developments are reshaping the landscape for developers and enterprises ali ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

You will be redirected to our submission process. The effects of climate change ... particularly zoonotic and vector-borne ...

Unsurprisingly, my last two columns discussed artificial intelligence (AI), specifically the impact of language models (LMs) on data curation. My August 2024 column, “The Shift from Syntactic to ...

GridGain, provider of a leading real-time data processing and analytics platform, is introducing GridGain for AI, enabling organizations to use GridGain as a low-latency data store for real-time AI ...